OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells
Barbara Schroeder, Travis Vander Steen, Ingrid Espinoza, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 64
Barbara Schroeder, Travis Vander Steen, Ingrid Espinoza, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 64
Showing 1-25 of 64 citing articles:
Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets
Sze Kiat Tan, Helen Y. Hougen, Jaime R. Merchan, et al.
Nature Reviews Urology (2022) Vol. 20, Iss. 1, pp. 48-60
Closed Access | Times Cited: 78
Sze Kiat Tan, Helen Y. Hougen, Jaime R. Merchan, et al.
Nature Reviews Urology (2022) Vol. 20, Iss. 1, pp. 48-60
Closed Access | Times Cited: 78
Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers
Jiaxuan Xu, Xiaoqing Dong, David C.S. Huang, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4957-4957
Open Access | Times Cited: 25
Jiaxuan Xu, Xiaoqing Dong, David C.S. Huang, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4957-4957
Open Access | Times Cited: 25
Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors
Amogh Gupta, Dipanwita Das, Reshma Taneja
Cancers (2024) Vol. 16, Iss. 7, pp. 1313-1313
Open Access | Times Cited: 16
Amogh Gupta, Dipanwita Das, Reshma Taneja
Cancers (2024) Vol. 16, Iss. 7, pp. 1313-1313
Open Access | Times Cited: 16
Venetoclax Resistance in Acute Myeloid Leukemia
Sylvain Garciaz, Marie‐Anne Hospital, Yves Collette, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1091-1091
Open Access | Times Cited: 11
Sylvain Garciaz, Marie‐Anne Hospital, Yves Collette, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1091-1091
Open Access | Times Cited: 11
Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications
Shiliang Xu, Lingxia Wang, Yuexin Zhao, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 10
Shiliang Xu, Lingxia Wang, Yuexin Zhao, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 10
Benchmarking the translational potential of spatial gene expression prediction from histology
Chuhan Wang, Adam S. Chan, Xiaohang Fu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Chuhan Wang, Adam S. Chan, Xiaohang Fu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer
Rohan Wedam, Yoshimi Endo Greer, David Wisniewski, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1936-1936
Open Access | Times Cited: 21
Rohan Wedam, Yoshimi Endo Greer, David Wisniewski, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1936-1936
Open Access | Times Cited: 21
Overexpression of fatty acid synthase attenuates bleomycin induced lung fibrosis by restoring mitochondrial dysfunction in mice
Hye‐Sun Shin, Shinhee Park, Jisu Hong, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Hye‐Sun Shin, Shinhee Park, Jisu Hong, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Fatty acid synthase: a druggable driver of breast cancer brain metastasis
Javier A. Menéndez, Ruth Lupu
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 5, pp. 427-444
Closed Access | Times Cited: 24
Javier A. Menéndez, Ruth Lupu
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 5, pp. 427-444
Closed Access | Times Cited: 24
WNT5A: a double-edged sword in colorectal cancer progression
Muhammad Tufail, Changxin Wu
Mutation Research/Reviews in Mutation Research (2023) Vol. 792, pp. 108465-108465
Closed Access | Times Cited: 13
Muhammad Tufail, Changxin Wu
Mutation Research/Reviews in Mutation Research (2023) Vol. 792, pp. 108465-108465
Closed Access | Times Cited: 13
The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy
Chou‐Yi Hsu, Mustafa Nasrat Abdulrahim, Mohammed Ahmed Mustafa, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access | Times Cited: 4
Chou‐Yi Hsu, Mustafa Nasrat Abdulrahim, Mohammed Ahmed Mustafa, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access | Times Cited: 4
The putative role of ferroptosis in gastric cancer: a review
Li Wang, Haibin Wang
European Journal of Cancer Prevention (2023) Vol. 32, Iss. 6, pp. 575-583
Open Access | Times Cited: 10
Li Wang, Haibin Wang
European Journal of Cancer Prevention (2023) Vol. 32, Iss. 6, pp. 575-583
Open Access | Times Cited: 10
Inferring Multi-slice Spatially Resolved Gene Expression from H&E-stained Histology Images with STMCL
Zhiceng Shi, Fangfang Zhu, Wenwen Min
Methods (2025)
Closed Access
Zhiceng Shi, Fangfang Zhu, Wenwen Min
Methods (2025)
Closed Access
Abnormalities in mitochondrial energy metabolism induced by cryopreservation negatively affect goat sperm motility
Shengqin Zang, Shuqi Zou, Xiangyi Chen, et al.
Frontiers in Veterinary Science (2025) Vol. 11
Open Access
Shengqin Zang, Shuqi Zou, Xiangyi Chen, et al.
Frontiers in Veterinary Science (2025) Vol. 11
Open Access
Targeting ferroptosis: a promising approach for treating lung carcinoma
Ziyang Wu, Tao Zhang, Wei Zhong, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Ziyang Wu, Tao Zhang, Wei Zhong, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
New UB006 Derivatives With Higher Solubility and Cytotoxic Activity in Ovarian Cancer Cells
Manuel Reina, Xavier Ariza, Dolors Serra, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 194-194
Open Access
Manuel Reina, Xavier Ariza, Dolors Serra, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 194-194
Open Access
Insights into curcumin’s anticancer activity in pancreatic ductal adenocarcinoma: Experimental and computational evidence targeting HRAS, CCND1, EGFR and AKT1
Jun‐Feng Cao, Xiao Zhang, Qingjie Xia, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108264-108264
Closed Access
Jun‐Feng Cao, Xiao Zhang, Qingjie Xia, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108264-108264
Closed Access
Multiple strategies association revealed functional candidate FASN gene for fatty acid composition in cattle
Bo Zhu, Tianzhen Wang, Qunhao Niu, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Bo Zhu, Tianzhen Wang, Qunhao Niu, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Fatty acid synthase (FASN) inhibition cooperates with BH3 mimetic drugs to overcome resistance to mitochondrial apoptosis in pancreatic cancer
Travis Vander Steen, Ingrid Espinoza, Cristina Duran, et al.
Neoplasia (2025) Vol. 62, pp. 101143-101143
Closed Access
Travis Vander Steen, Ingrid Espinoza, Cristina Duran, et al.
Neoplasia (2025) Vol. 62, pp. 101143-101143
Closed Access
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
Mengting Wan, Shuaikang Pan, Benjie Shan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Mengting Wan, Shuaikang Pan, Benjie Shan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Cell Progression and Survival Functions of Enzymes Secreted in Extracellular Vesicles Associated with Breast and Prostate Cancers
Cosmos Ifeanyi Onyiba, Namita Kumar, Christopher J. Scarlett, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 468-468
Open Access
Cosmos Ifeanyi Onyiba, Namita Kumar, Christopher J. Scarlett, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 468-468
Open Access
Fatty acid synthase inhibitor cerulenin attenuates glioblastoma progression by reducing EMT and stemness phenotypes, inducing oxidative and ER stress response, and targeting PI3K/AKT/NF-κB axis
Murat Pekmez, Şefika Beyza Mete, Yunus Aksüt, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Open Access
Murat Pekmez, Şefika Beyza Mete, Yunus Aksüt, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Open Access
LDLR-targeted orlistat therapeutic nanoparticles: Peptide selection, assembly, characterization, and cell-uptake in breast cancer cell lines
George Bebawy, Pamela Collier, Philip M. Williams, et al.
International Journal of Pharmaceutics (2025), pp. 125574-125574
Open Access
George Bebawy, Pamela Collier, Philip M. Williams, et al.
International Journal of Pharmaceutics (2025), pp. 125574-125574
Open Access
Uncovering Shared and Tissue-Specific Molecular Adaptations to Intermittent Fasting in Liver, Brain, and Muscle
Yibo Fan, Senuri De Silva, Nishat I. Tabassum, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Yibo Fan, Senuri De Silva, Nishat I. Tabassum, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma
Ugo Chianese, Chiara Papulino, Ahmad H. Ali, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Ugo Chianese, Chiara Papulino, Ahmad H. Ali, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
